Your session is about to expire
← Back to Search
Behavioral Intervention
STAMP+CBT App for Cancer Pain
N/A
Recruiting
Led By Desiree Azizoddin, PsyD
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
This trial will test a new app designed to help cancer patients with pain.
Who is the study for?
This trial is for adults over 18 with chronic pain from cancer or its treatment, who are being treated at specific clinics and have a smartphone. They must be undergoing active cancer treatment or palliative care, have a pain score over 4, and take opioids for cancer pain (not post-surgical). Excluded are non-English speakers, hospitalized patients, those in remission or survivorship phase, with cognitive impairments, history of opioid misuse, enrolled in hospice or using transmucosal fentanyl.Check my eligibility
What is being tested?
The study tests an mHealth app called STAMP+CBT designed to assist patients managing cancer-related chronic pain. The effectiveness of the mobile application in improving patient outcomes will be evaluated among participants who meet the criteria.See study design
What are the potential side effects?
Since this trial involves a mobile application rather than medication there may not be direct 'side effects' like drugs; however users might experience stress or frustration if they find the technology difficult to use.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acceptability Rate
Overall Intervention Adherence Rate
Secondary outcome measures
COMPREHENSIVE ENDPOINT
Study Accrual Rate
Study retention
Trial Design
1Treatment groups
Experimental Treatment
Group I: STAMP+CBT PILOTExperimental Treatment1 Intervention
Patients in this Pilot Cohort will be in the research study for 6 weeks total including:
a 4-week intervention period and 2-week post intervention period.
Patients will use the app for a total of 4 weeks (4-week intervention period), and will complete surveys at baseline, 4 weeks (end of intervention period), and at 6 weeks (end of 2-week post intervention period).
Find a Location
Who is running the clinical trial?
Dana-Farber Cancer InstituteLead Sponsor
1,080 Previous Clinical Trials
341,218 Total Patients Enrolled
1 Trials studying Palliative Care
104 Patients Enrolled for Palliative Care
National Palliative Care Research Center (NPCRC)UNKNOWN
1 Previous Clinical Trials
62 Total Patients Enrolled
Desiree Azizoddin, PsyDPrincipal InvestigatorDana-Farber Cancer Institute
1 Previous Clinical Trials
60 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have pain mostly from a recent surgery.You are not currently receiving treatment for advanced cancer, or your cancer is in remission.You have trouble thinking or remembering things that may affect your ability to take part in the study, according to your doctor.You have a history of addiction to opioid drugs.You are currently in hospice care.You have ongoing pain from cancer or its treatment that rates higher than 4 on a pain scale.You are using transmucosal fentanyl, which has safety concerns and requires a special program to prescribe.You have been diagnosed with cancer and are currently receiving cancer treatment or palliative care.You are currently taking opioid medication for your cancer pain.
Research Study Groups:
This trial has the following groups:- Group 1: STAMP+CBT PILOT
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any openings for participants in this experiment?
"According to information posted on clinicaltrials.gov, this study is still enrolling patients; the first posting was made in July 2022 and it has been updated as recently as November 17th of that same year."
Answered by AI
How many individuals are currently involved in this clinical experiment?
"Affirmative. The information hosted on clinicaltrials.gov suggests that this medical trial, which was first published on July 1st 2022, is actively seeking applicants. Specifically, it requires 15 participants across 3 distinct sites to be recruited."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger